Medical News

RSS

HHS: $250 million in grants available for New Access Points for delivery of primary health care services

U.S. Department of Health and Human Services Secretary Kathleen Sebelius announced today the availability of up to $250 million in grants for New Access Points for the delivery of primary health care services for underserved and vulnerable populations under the Health Center Program. The funds, made available by the Affordable Care Act, will be awarded by the Health Resources and Services Administration (HRSA).

10 Aug 2010

Epitherix identifies potent and selective multiple chemical scaffolds against colorectal carcinoma

Epitherix, LLC, a privately held company focused on the discovery and development of novel Wnt pathway small molecule inhibitors for epithelial and leukemic cancers, today announced that it has identified multiple chemical scaffolds that are potent and selective against colorectal carcinoma. "We're very encouraged by our in vitro and in vivo data, especially considering the difficulty in drugging this pathway to date," said Dr. Osman Kibar, CEO of Epitherix.

10 Aug 2010

Alnylam Pharmaceuticals reports significant progress in discovery of novel technologies for systemic delivery of RNAi therapeutics

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators from the Massachusetts Institute of Technology (MIT), The University of British Columbia (UBC), AlCana Technologies, Inc., and Tekmira Pharmaceuticals Corporation, presented results from multiple ongoing research efforts regarding the discovery of novel technologies for the systemic delivery of RNAi therapeutics.

10 Aug 2010

Pharmasset third-quarter net loss increases to $16.0 million

Pharmasset, Inc., a clinical stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections, today reported financial results and operational highlights for the quarter ended June 30, 2010.

10 Aug 2010

UT Southwestern enters partnership with Sun Yat-sen University to promote scientific research

UT Southwestern Medical Center has entered into an academic and scientific partnership with Sun Yat-sen University and its First Affiliated Hospital in Guangzhou, China. The first international institutional affiliation for UT Southwestern and a first step in implementing the global health initiative that is one of the medical center's current strategic priorities, the partnership was developed to promote joint scientific research, educational, and training activities.

10 Aug 2010

Cancer Research Technology grants Scancell licence to use 105AD7 human antibody

Scancell Holdings Plc,, the developer of therapeutic cancer vaccines, and Cancer Research Technology Ltd - Cancer Research UK's commercialisation and development arm - today announce that they have signed an agreement under which Scancell has been granted a licence to use a human antibody known as 105AD7.

10 Aug 2010

Raptor Pharmaceutical to raise $15 million through PIPE financing

Raptor Pharmaceutical Corp., announced it has entered into a securities purchase agreement in connection with a private placement, or PIPE financing. Upon the closing of the PIPE financing, Raptor will receive gross proceeds of approximately $15 million resulting from the sale of 4,897,614 units at a purchase price of $3.075 per unit.

10 Aug 2010

Texas Children's Hospital provides tips to ensure healthy and successful school year

It's August and for many families that means it's time to head back to school. From sleep schedules, nutrition, immunizations, heart health, heat illnesses and more, Texas Children's Hospital in Houston provides parents with tips to ensure their children have a safe, healthy and successful school year.

10 Aug 2010

CareView files patent for innovative technology to prevent decubitus ulcers

CareView Communications, Inc. ("CareView" or the "Company"), an information technology provider to the healthcare industry, announced that it has filed a new patent with the United States Patent and Trademark Office to cover an innovative technology that will assist hospitals and other medical facilities in their efforts to prevent decubitus ulcers or "bed sores" experienced by patients. CareView's new product covered by the pending patent uses the CareView System monitoring system to ensure timely patient movement which assists caregivers in the prevention and treatment of bed sores.

10 Aug 2010

Phase Forward second-quarter GAAP revenues increase 12% to $58.6 million

Phase Forward Incorporated today announced its financial results for the second quarter of 2010.

10 Aug 2010

Computerized warning system alerts harmful drug orders for older hospital patients

Adverse drug events, such as dizziness or confusion occur in an estimated 40 percent of all hospital patients and can be the result of inappropriate medications being ordered. Not surprisingly, elderly individuals are particularly vulnerable to these adverse events, which not only result in longer hospitalizations, but can also pose a threat of serious complications and even death.

10 Aug 2010

Oil rig workers access healthcare via telemedicine

Without hands-on access to doctors and hospitals, oil rig workers who become sick or injured increasingly rely on telemedicine "visits" with physicians and specialists on land, a trend explored in detail in an article published in Telemedicine and e-Health, a peer-reviewed journal published by Mary Ann Liebert, Inc.

10 Aug 2010

ADA updates position paper on children’s healthy behaviors

The American Dietetic Association has published an updated position paper on local support for nutrition integrity in schools that calls on schools and communities to work together to provide healthful and affordable meals for all children and to promote educational environments that help students learn and practice healthy behaviors for their entire lives.

10 Aug 2010

Unigene second-quarter revenue decreases to $3.03 million

Unigene Laboratories, Inc. has reported its financial results for the quarter ended June 30, 2010.

10 Aug 2010

Brain-wave pattern study may lead to techniques for enhancing sleep spindles

People who have trouble sleeping in noisy environments often resort to strategies like earplugs or noise-cancelling headphones that muffle the sound, but a new study from investigators at Massachusetts General Hospital (MGH) may lead to ways to block disturbing sounds within the brain. In their report in the August 10 issue of Current Biology, the team reports finding a brain-wave pattern, reflecting activity of a key structure, that predicts the ease at which sleep can be disrupted by noise.

10 Aug 2010

Systemic lupus erythematosus drug market to quadruple from $400 million in 2009 to over $1.6 billion in 2019

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, driven primarily by the launch and uptake of Human Genome Sciences/GlaxoSmithKline's Benlysta, the systemic lupus erythematosus (SLE) drug market will quadruple from about $400 million in 2009 to more than $1.6 billion in 2019 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

10 Aug 2010

Synta second-quarter net loss increases to $9.1 million

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today reported financial results for the quarter ended June 30, 2010.

10 Aug 2010

Scientific paper explains impact of visual cycle modulation in neurovascular retinopathy

Acucela, a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that a scientific paper co-authored by Ryo Kubota, M.D., Ph.D., chairman, president and chief executive officer of Acucela, has been published in Experimental Eye Research. The paper, "Visual Cycle Modulation in Neurovascular Retinopathy" was also co-authored by scientists from Children's Hospital and Harvard Medical School in Boston and demonstrates for the first time the impact of treatment with a visual cycle modulator (VCM) on retinopathy in an immature eye.

10 Aug 2010

Array BioPharma fiscal 2010 revenue increases to $53.9 million

Array BioPharma Inc. today reported financial results for the fourth quarter and full year of fiscal 2010.

10 Aug 2010

Elan and Transition Therapeutics report results of ELND005 Phase 2 study for Alzheimer's disease

Elan Corporation, plc and Transition Therapeutics, Inc today announced the results of a Phase 2 placebo-controlled study in 351 patients with mild to moderate Alzheimer's disease who received study drug for up to 18 months (Study AD201). Study subjects with MMSE scores between 16 and 26 received ELND005 oral doses of 250 mg, 1000 mg or 2000 mg twice daily or matching placebo. The study's cognitive (NTB) and functional (ADCS-ADL) co - primary endpoints did not achieve statistical significance.

10 Aug 2010

Medical News

HHS: $250 million in grants available for New Access Points for delivery of primary health care services

Epitherix identifies potent and selective multiple chemical scaffolds against colorectal carcinoma

Alnylam Pharmaceuticals reports significant progress in discovery of novel technologies for systemic delivery of RNAi therapeutics

Pharmasset third-quarter net loss increases to $16.0 million

UT Southwestern enters partnership with Sun Yat-sen University to promote scientific research

Cancer Research Technology grants Scancell licence to use 105AD7 human antibody

Raptor Pharmaceutical to raise $15 million through PIPE financing

Texas Children's Hospital provides tips to ensure healthy and successful school year

CareView files patent for innovative technology to prevent decubitus ulcers

Phase Forward second-quarter GAAP revenues increase 12% to $58.6 million

Computerized warning system alerts harmful drug orders for older hospital patients

Oil rig workers access healthcare via telemedicine

ADA updates position paper on children’s healthy behaviors

Unigene second-quarter revenue decreases to $3.03 million

Brain-wave pattern study may lead to techniques for enhancing sleep spindles

Systemic lupus erythematosus drug market to quadruple from $400 million in 2009 to over $1.6 billion in 2019

Synta second-quarter net loss increases to $9.1 million

Scientific paper explains impact of visual cycle modulation in neurovascular retinopathy

Array BioPharma fiscal 2010 revenue increases to $53.9 million

Elan and Transition Therapeutics report results of ELND005 Phase 2 study for Alzheimer's disease

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News